NBR has won the Qantas Media Award for "Best Single Report on a  Website" for the story "Most people won't get their money back." 

Business and finance publication Forbes has just dealt another setback to Usana Health Sciences, a vitamin company with thousands of distributors in New Zealand which – as NBR reported last month – is already facing shareholder lawsuits, falling stock prices and an FBI investigation.

Under the headline “Hard to Swallow,” Forbes quoted industry and government experts who raised questions about Usana’s business practices as well as its products.

UPDATED 2008: USANA Health Sciences, Inc. (NASDAQ: USNA) announced today that a California State court has dismissed the distributor class action suit, Johnson v. USANA, filed in 2007 against the company and certain of its officers, distributors and directors. The Plaintiffs agreed to request that the court dismiss the case with prejudice after plaintiffs reviewed recent evidence and determined there was no longer any merit to maintaining a class action lawsuit.